LoginRegister

    Lupin launches pain relieving tablets in US

    Written by Ruby Khatun Khatun   |  
    Lupin launches pain relieving tablets in US

    New Delhi: Drug firm Lupin said it has launched its pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market.


    The company has launched Hydrocodone Bitartrate and Acetaminophen tablets USP in the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval from the US Food and Drug Administration (USFDA), Lupin said in a BSE filing.


    The company's product is a generic version of Allergan Sales LLCs Norco tablets in the same strengths and is indicated for the relief of moderate to moderately severe pain, it added.


    As per IMS MAT June 2017 data, Hydrocodone Bitartrate and Acetaminophen tablets had annual sales of around USD 710 million.

    Acetaminophen tabletsAllerganAmerican marketgenericHydrocodone Bitartrateindian pharma newslaunchesLupinNorco tabletspainpain drugpain relieving tabletspharma newspharma news indiaUS
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X